Clonixeril
Clonixeril (NSC 335504) is a non-nucleotide hSTING modulator. Clonixeril has weak agonist activity at micromolar concentrations and results in antagonism of the hSTINGWT pathway at low femtomolar (10-15 M) and in some cases even attomolar (10-18 M) concentrations. Clonixeril reduces hSTING oligomerization at a concentration of 1 aM-1 pM[1].
Product Specifications
CAS Number
21829-22-1
Product Name Alternative
NSC 335504
UNSPSC
12352005
Target
STING
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Smiles
O=C(C1=CC=CN=C1NC2=C(C)C(Cl)=CC=C2)OCC(CO)O
Molecular Formula
C16H17ClN2O4
Molecular Weight
336.77
References & Citations
[1]Robert P. Sparks, et al. Discovery of Clonixeril as a Sub-Femtomolar Modulator of the Human STING Receptor. ACS Central Science Article ASAP
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
032293-ML550 100 µL
ATP6V0A4, ID (ATP6V0A4, ATP6N1B, ATP6N2, V-type proton ATPase 116kD subunit a isoform 4, Vacuolar proton translocating ATPase 116kD subunit a isoform 4, Vacuolar proton translocating ATPase 116kD subunit a kidney isoform) (MaxLight 550) discontinued
Sign In for Pricing
View Details